Kayyem Jon Faiz

CIK 00013662683 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001366268

Recent Transactions

36 trades

Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.26/sh−9,500→ 3,224,301 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.26/sh−9,500→ 3,224,301 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.26/sh−9,500→ 3,224,301 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.26/sh−9,500→ 3,224,301 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.26/sh−9,500→ 3,224,301 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.26/sh−9,500→ 3,224,301 total
Sale
GenMark Diagnostics, Inc.
Common Stock
2014-01-02$13.18/sh−6,000→ 100,934 total
Sale
GenMark Diagnostics, Inc.
Common Stock
2014-01-02$13.18/sh−100,000→ 619,308 total
Sale
GenMark Diagnostics, Inc.
Common Stock
2014-01-02$13.18/sh−6,000→ 100,934 total
Sale
GenMark Diagnostics, Inc.
Common Stock
2014-01-02$13.18/sh−100,000→ 619,308 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-19$9.84/sh+43,500
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-19$9.84/sh+43,500
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-19$9.84/sh+43,500
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-19$9.84/sh+43,500
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-19$9.84/sh+43,500
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-19$9.84/sh+43,500
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-18$9.79/sh+42,100
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-18$9.79/sh+42,100
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-18$9.79/sh+42,100
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-18$9.79/sh+42,100
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-18$9.79/sh+42,100
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-18$9.79/sh+42,100

Companies

Recent Filings

Address

C/O INHIBRX, INC. 11025 NORTH TORREY PINES ROAD, SUITE 200

LA JOLLA, CA, 92037

View on SEC.gov